Rockville-based Sucampo Pharmaceuticals Inc. finalized its acquisition of the Japanese biotech R-Tech Ueno for $275 million, officials said Monday.
In August, Sucampo (NASDAQ: SCMP) made a $278 million all-cash offer to acquire R-Tech Ueno, a Japanese pharmaceutical company that manufactures Amitiza, Sucampo’s flagship drug that eases drug-related constipation using fatty acid-derived compounds known as prostones.
{iframe}http://www.bizjournals.com/washington/blog/2015/12/sucampo-pharmaceuticals-closes-275-million-deal.html?ana=e_du_pap&s=article_du&ed=2015-12-07&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1449519934{/iframe}